Charles Smith
Ask VT AI
View News Summary
- Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent industry challenges.
- Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
- Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent industry challenges.
- Vulcan Materials reports strong Q3 results, expects continued growth in construction materials demand driven by infrastructure spending.
- Novo Nordisk challenges Pfizer's acquisition of Metsera with a $6.5 billion bid, sparking a high-stakes contest for obesity and GLP-1 assets.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Charles Smith
News from Charles Smith
